<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[mylan laboratories inc. Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/mylan+laboratories+inc..html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to mylan laboratories inc.]]></description>
	<s:counts start="0" returned="20" found="85" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Mylan Pharmaceuticals Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3007/is_16_29/ai_n29379587]]></link>
		<description><![CDATA[1500 Corporate Dr.  Canonsburg, Pa. 15317  Key contact:  HARRY KORMAN, President  Phone: (724)-514-1800  Fax: 724-514-1870  www.mylan.com  CANONSBURG, Pa. -- Mylan Laboratories Inc. is one of the world's leading generics and speciality pharmaceutical companies. As one of the generics industry's pioneers, Mylan has remained...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 17 Sep 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Mylan Announces the U.S. District Court Enjoins the FDA from Approving Additional Amlodipine Besylate ANDAs.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5243/is_200703/ai_n20187594]]></link>
		<description><![CDATA[M2 PRESSWIRE-27 March 2007-Afternoon Movers: Mylan Announces the  U.S. District Court Enjoins the FDA from Approving Additional Amlodipine  Besylate ANDAsC1994-2007 M2 COMMUNICATIONS LTD    RDATE:27032007    Market Gainer is quickly emerging as the one stop shop for  international small-cap investors looking to stay...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 27 Mar 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/investor.html"><![CDATA[investor]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/security.html"><![CDATA[security]]></category>
		<category domain="http://resources.bnet.com/topic/u.s.+district+court.html"><![CDATA[U.S. District Court]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Zacks Buy List Highlights: Mylan Laboratories, Inc., C.H. Robinson Worldwide, Inc., AeroCentury Corp. and Argonaut Group, Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Feb_8/ai_n27141910]]></link>
		<description><![CDATA[CHICAGO -- Zacks.com releases the latest list of Zacks Rank Buy Stocks. Everyday on Zacks.com, four stocks are selected based on how well they match the criteria for the four main schools of investing: Aggressive Growth, Growth & Income, Momentum and Value. The four Zacks Rank Buy stocks highlighted today...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 08 Feb 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Leerink Swann & Company Initiates Coverage of Barr Pharmaceuticals, Inc. (NYSE: BRL) Mylan Laboratories Inc. (NYSE: MYL)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200512/ai_n15939563]]></link>
		<description><![CDATA[This morning, Senior Generic Pharmaceutical Analyst, William F. Sawyer, initiated coverage of Barr Pharmaceuticals (NYSE: BRL) with an Outperform rating and Mylan Laboratories Inc. (NYSE: MYL) with a Market Perform rating. He bases his investment rating for Barr on his view that solid operating performance from Barr's generic and branded...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 16 Dec 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/barr+pharmaceuticals+inc..html"><![CDATA[Barr Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BRL</category>
		<category domain="tickers">BRL</category>
	</item>
	<item>
		<title><![CDATA[A Review of Mylan Laboratories Inc from 2000 to 2005 Covering Financial Information, Deals Made, and Its Subsidiaries with 48 Partnering Companies]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Nov_11/ai_n15791823]]></link>
		<description><![CDATA[DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c26878) has announced the addition of Mylan Laboratories Inc Deals Briefing to their offering.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 11 Nov 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Zacks Buy List Highlights: Ceradyne, Inc., Mylan Laboratories, Inc., Cognizant Technology Solutions Corp., and Goodrich Corporation]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_Sept_23/ai_n15628609]]></link>
		<description><![CDATA[CHICAGO -- Zacks.com releases another list of stocks that are currently members of the coveted Zacks #1 Rank Strong Buy List. The #1 Rank stocks highlighted today are Ceradyne, Inc. (NASDAQ:CRDN) and Mylan Laboratories, Inc. (NYSE:MYL). Further, Zacks announced #2 Rankings Buy on two other widely held stocks: Cognizant Technology...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 23 Sep 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/ceradyne+inc..html"><![CDATA[Ceradyne Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CRDN</category>
		<category domain="tickers">CRDN</category>
	</item>
	<item>
		<title><![CDATA[Late News; Sinnott to return to MMC as vice chair.(John T. Sinnott to join Marsh & McLennan Cos. Inc.)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5252/is_200506/ai_n20162311]]></link>
		<description><![CDATA[John T. Sinnott is returning to Marsh & McLennan Cos. Inc. as  vice chairman. Mr. Sinnott, who worked at MMC brokerage unit Marsh Inc.  for 40 years, retired as chairman of the unit in July 2003. On his  retirement, he became a senior adviser to the ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 06 Jun 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[MARKET ALERTS: "HEE Corporation -- Clinical Trial at a Major University"]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200411/ai_n8560559]]></link>
		<description><![CDATA[eLocity's velocity stocks to watch for today are: HEE Corporation (OTC: HCCF), Aastrom Biosciences, Inc. (NASDAQ: ASTM), Biopure Corporation (NASDAQ: BPUR), Mylan Laboratories Inc. (NYSE: MYL)  Investors will surely want to keep an eye on HEE Corporation (OTC: HCCF). HEE Corporation announced after the closing bell on Tuesday that...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 03 Nov 2004 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/compensation.html"><![CDATA[compensation]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[MARKETING]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/newsletter.html"><![CDATA[newsletter]]></category>
		<category domain="http://resources.bnet.com/topic/oxygen.html"><![CDATA[oxygen]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Mylan Pharmaceuticals Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3007/is_16_25/ai_n29056937]]></link>
		<description><![CDATA[781 Chestnut Ridge Rd. Morgantown, W. Va. 26505-4310  Phone: (304) 599-2595 Fax: (304) 598-3232  Web site: mylan.com; mylanpharms.com  Key contact: Jason Harper, associate director of marketing  MORGANTOWN, W.Va. -- Mylan Pharmaceuticals Inc.'s parent company Mylan Laboratories Inc. announced financial results for the first quarter ended June...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 29 Sep 2003 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Omeprazole. (Pharma in Brief).(Mylan Pharmaceuticals launches delayed release capsules)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200308/ai_n13359853]]></link>
		<description><![CDATA[OMEPRAZOLE Mylan Laboratories Inc., through its wholly owned  subsidiary Mylan Pharmaceuticals Inc., has launched 10 mg and 20 mg  omeprazole delayed release capsules. The drug is the generic version of  AstraZeneca PLC's Prilosec.   ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 11 Aug 2003 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[MYLAN Laboratories Inc. (Active Pharmaceutical Ingredient Watch).(gets FDA approval for omeprazole delay-release capsules)(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200306/ai_n13212185]]></link>
		<description><![CDATA[MYLAN Laboratories Inc. has received final Food and Drug  Administration FDA approval for its abbreviated new drug application  for omeprazole ...    MYLAN Laboratories Inc. has received final Food and Drug  Administration FDA approval for its abbreviated new drug application  for omeprazole delayed-release capsules,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 09 Jun 2003 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Robert J.Coury.(Newsmakers)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6606/is_200306/ai_n26356857]]></link>
		<description><![CDATA[* Mylan Laboratories Inc. named Robert J. Coury chief executive  officer. Coury has been serving as a consultant to Mylan since 1995. He  has already been appointed ...  * Mylan Laboratories Inc. named Robert J. Coury chief executive  officer. Coury has been serving as a consultant...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 01 Jun 2003 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/robert.html"><![CDATA[Robert]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Cambrex stock crashes on major profit warning; Mylan settlement adds to woes: 2003 EPS forecast revised to $1.05 to $1.25 versus $2 to $2.15. (Financial).]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200304/ai_n13360293]]></link>
		<description><![CDATA[NOT LONG AGO a darling of Wall Street, Cambrex Corp. saw its shares  plunge by more than one-third as it dramatically slashed 2003 profit  projections in the face of the loss of a major contract  biopharmaceutical manufacturing customer, a tentative legal settlement  with Mylan Laboratories Inc.,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 14 Apr 2003 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cambrex+corp..html"><![CDATA[Cambrex Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/j.p.+morgan+chase+%2526+co..html"><![CDATA[J.P. Morgan Chase & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[SALES]]></category>
		<category domain="http://resources.bnet.com/topic/settlement.html"><![CDATA[settlement]]></category>
		<category domain="http://resources.bnet.com/topic/stock.html"><![CDATA[stock]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CBM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JPM</category>
		<category domain="tickers">CBM,JPM</category>
	</item>
	<item>
		<title><![CDATA[Pittsburgh Post-Gazette Business Briefs Column.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5553/is_200212/ai_n22122678]]></link>
		<description><![CDATA[Pittsburgh Post-Gazette Knight Ridder/Tribune Business News    Dec. 21--CONCERN TO END EPHEDRA OUTPUT: A Florida maker of weight  management products will discontinue all those containing ephedra  because a  supplier has been unable to get liability insurance for such  products.    Health &...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 21 Dec 2002 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/general+nutrition+centers+inc..html"><![CDATA[General Nutrition Centers Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Mylan wins FDA approval for generic Accutane. (Markets: Life Sciences).(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb4250/is_200211/ai_n13272874]]></link>
		<description><![CDATA[MYLAN LABORATORIES Inc. has received Food and Drug Administration  FDA approval for its generic version of Roche's acne drug  Accutane/Roaccutan isotretinoin.       Mylan's branded subsidiary Bertek Pharmaceuticals Inc. will  market isotretinoin u    MYLAN LABORATORIES Inc. has received Food and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 18 Nov 2002 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/life+science.html"><![CDATA[life science]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[sales]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Mylan Laboratories Inc. Announces First ANDA Approval for Isotretinoin; Bertek Pharmaceuticals Inc. to Market Amnesteem]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_Nov_11/ai_94113462]]></link>
		<description><![CDATA[Business Editors/Health & Medical Writers]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 11 Nov 2002 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Mylan Reports Record Second Quarter EPS of $.54]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_Oct_29/ai_93510538]]></link>
		<description><![CDATA[Business Editors      PITTSBURGH--BUSINESS WIRE--Oct. 29, 2002--                           Financial Highlights      -  Net revenues increased 12%...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 29 Oct 2002 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Mylan Pharmaceuticals Inc]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb3007/is_16_24/ai_n28947825]]></link>
		<description><![CDATA[781 Chestnut Ridge Rd.  Morgantown, W.Va. 26505-4310  Phone: (304) 599-2595  (800) 796-9526  Fax: (304) 598-3232  Web site: mylan.com; mylanpharms.com  MORGANTOWN, W.Va. -- Life at 40 is proving to be a busy time for Mylan Pharmaceuticals Inc.  A year after celebrating the completion of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 30 Sep 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+pharmaceuticals+inc..html"><![CDATA[Mylan Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Spencer Stuart/Directors & Boards Directors Roster. (H-Z). ]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_go2446/is_200206/ai_n7043508]]></link>
		<description><![CDATA[HAGGAR CORP.   6113 Lemmon Avenue, Dallas, TX 75209    has added to its board:    Donald E. Godwin    Chairman and CEO    GODWIN GRUBER PC    1201 Elm Street, Suite 1700, Dallas, TX 75270   ...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 22 Jun 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/blackstone+group+lp.html"><![CDATA[Blackstone Group LP]]></category>
		<category domain="http://resources.bnet.com/topic/computer+associates+international+inc..html"><![CDATA[Computer Associates International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/continental+airlines+inc..html"><![CDATA[Continental Airlines Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/csx+corp..html"><![CDATA[CSX Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/hillenbrand+industries+inc..html"><![CDATA[Hillenbrand Industries Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/johnson+%2526+johnson.html"><![CDATA[Johnson & Johnson]]></category>
		<category domain="http://resources.bnet.com/topic/knowledgemax+inc..html"><![CDATA[KnowledgeMax Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/marriott+international+inc..html"><![CDATA[Marriott International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/mckesson+corp..html"><![CDATA[McKesson Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/northwest+airlines+corp..html"><![CDATA[Northwest Airlines Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/petco+animal+supplies+inc..html"><![CDATA[PETCO Animal Supplies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pogo+producing+co..html"><![CDATA[Pogo Producing Co.]]></category>
		<category domain="http://resources.bnet.com/topic/pss+world+medical+inc..html"><![CDATA[PSS World Medical Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/rayovac+corp..html"><![CDATA[Rayovac Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/rent-a-center+inc..html"><![CDATA[Rent-A-Center Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/riviera+holdings+corp..html"><![CDATA[Riviera Holdings Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/saks+inc..html"><![CDATA[Saks Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/take-two+interactive+software+inc..html"><![CDATA[Take-Two Interactive Software Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/taser+international+inc..html"><![CDATA[TASER International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CAL</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CSX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">HB</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JNJ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MAR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MCK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NWACQ.PK</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PSSI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RCII</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RIV</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SKS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TTWO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TASR</category>
		<category domain="tickers">BX,CAL,CSX,HB,JNJ,MAR,MCK,NWACQ.PK,PSSI,RCII,RIV,SKS,TTWO,TASR</category>
	</item>
	<item>
		<title><![CDATA[Mylan Reports Record Revenues and Earnings For The Fourth Quarter and Fiscal 2002]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_May_8/ai_85515604]]></link>
		<description><![CDATA[Business Editors  PITTSBURGH--BUSINESS WIRE--May 8, 2002  Mylan Laboratories Inc.(NYSE: MYL)- Financial Highlights:  - Net revenues increased 30% to exceed $1.1 billion for the fiscal year and 14% to $282.6 million for the quarter.  - Gross profit increased 63% to $623.9 million for the fiscal year and...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 08 May 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/brand.html"><![CDATA[brand]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[earnings]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/ftc.html"><![CDATA[FTC]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/mylan+laboratories+inc..html"><![CDATA[Mylan Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/r%2526d.html"><![CDATA[R&D]]></category>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[revenue]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[sales]]></category>
		<category domain="http://resources.bnet.com/topic/settlement.html"><![CDATA[settlement]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
